Tarun Sai Lomte

Tarun Sai Lomte

MSc Biotechnology

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing. During his Master’s, he developed an interest in Developmental Biology, Genetic Engineering, Immunology, and Bioinformatics and is keen on understanding the present-day developments in these domains. He has worked on molecular modeling, docking, and simulations for his Master’s thesis and cherishes the time spent in his academic life, especially the in-lab experience with his peers and instructors.

See more

As a Bachelor’s student, he went on several field visits to different scientific laboratories researching fundamental and applied sciences which inspired him to pursue higher studies. He was also very involved in several academic activities such as science quizzes, presentations, and discussions. Besides life sciences, he is intrigued about the cosmos and follows the latest developments made in Astronomy by different space agencies. In his free time, Tarun enjoys traveling and watching cricket with a particular interest in the test format of the game. He likes watching movies and web series based on Sci-Fi, Fantasy, and Drama genres.

See less

Articles from Tarun

Mathematical modeling the vaccination of children against SARS-CoV-2

Mathematical modeling the vaccination of children against SARS-CoV-2

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

Humoral and cellular response to primary and booster COVID-19 vaccination in immunosuppressed patients

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

SARS-CoV-2 Omicron variant uses endosomal entry pathway and grows in upper respiratory tract cells

Scientists assess effectiveness of neutralizing antibodies against seven SARS-CoV-2 variants, including Omicron

Scientists assess effectiveness of neutralizing antibodies against seven SARS-CoV-2 variants, including Omicron

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

SARS-CoV-2 differs from other betacoronaviruses in a key IRE1α/XBP1 pathway

SARS-CoV-2 differs from other betacoronaviruses in a key IRE1α/XBP1 pathway

The impact of natural selection on sequence diversity in SARS-CoV-2

The impact of natural selection on sequence diversity in SARS-CoV-2

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

T-cell responses to SARS-CoV-2 Omicron variant confer protection to vaccinated individuals

Omicron infection induces cross-reactive immune responses

Omicron infection induces cross-reactive immune responses

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

Reviewing myocarditis and pericarditis in immunosuppressed individuals following COVID-19 mRNA vaccination

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.